Effects of thymol on urinary parameters related to lithogenesis;Efeitos do timol sobre os parâmetros urinários envolvidos na formação de cálculos

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 45, Issue 4, 2009, Pages 269-274

  Ferraz, Renato Ribeiro Nogueira ^a   Da Silva Moreira, Silvia Regina ^b   Heilberg, Ita Pfeferman ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO RIM E HIPERTENSÃO   (Brazil)

Author keywords

Lithiasis; Preservatives; Thymol; Urinary parameters

Indexed keywords

EID: 73449096423     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ASPLIN, J. et al. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol, v. 159, n. 6, p. 1821-1825, 1998.
2. BAXMANN, A.C.; MENDONÇA, C.O.G.; HEILBERG, I.P. Effect of vitamin C supplements on urinary oxalate and pH In calcium stone-forming patients. Kidney lnt, v. 63, n. 3, p. 1066-1071, 2003. (Pubitemid 36315585)
3. BRAIOTTA, E.A.; BUTERRY, J.E.; LUDVIGSEN, N. The effects of pH, temperature and storage on urine oxalate. Clin Chim Acta, v. 147, n. 1, p. 31-34, 1985. (Pubitemid 15117252)
4. COE, F.L.; EVAN, A.; WORCESTER, E. Kidney stone disease. J Clin Invest, v. 115, n. 10, p. 2598-2608, 2005.
5. CURHAN, G.C. et al. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney lnt, v. 59, n. 6, p. 2290-2298, 2001. (Pubitemid 32467623)
6. FERRAZ, R.R. et al. Preservation of urine samples for metabolic evaluation of stone-forming patients. Urol Res, v. 34, n. 5, p. 329-337, 2006.
7. FOSSATI, P.; PRENCIPE, L.; BERTI, G. Use of 3,5-dichloro2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem, v. 26, n. 2, p. 227-231, 1980.
8. GRIFFITH, D.P.; DUNN, D. Collection and preservation of urine for biochemical analyses. Invest Urol, v. 15, n. 6, p. 459-461, 1978.
9. HALLSON, P.C.; ROSE, G.A. A simplified and rapid enzymatic method for the determination of urinary oxalate. Clin Chim Acta, v. 55, n. 1, p. 29-39, 1974.
10. HEILBERG, I.P; SCHOR, N. Renal stone disease: Causes, evaluation and medical treatment. Arq Bras Endocrinol Metabol, v. 50, n. 4, p. 823-831, 2006.
11. HODGKINSON, A. Sampling errors in the determination of urine calcium and oxalate: solubility of calcium oxalate in HCl-urine mixtures. Clin Chem Acta, v. 109, n. 2, p. 239-244, 1981.
12. HOLT, C.; COWLEY, D.M.; CHALMERS, A.H. Rapid estimation of urinary citrate by use of a centrifugal analyzer. Clin Chem, v. 31, n. 5, p. 779-780, 1985.
13. LAERUM, E.; PALMER, H. Methodological aspects of examination of 24-hour urinary excretions In outpatients with recurrent urolithiasis. Scand J Urol Nephrol, v. 17, n.3, p. 321-324, 1983.
14. LEVY, F.L.; ADAMS-HUET, B.; PAK, C.Y. Ambulatory evaluation of Nephrolithiasis: an update of a 1980 protocol. Am J Med, v. 98, n.l, p. 5-59, 1995.
15. LI, M.G.; MADAPPALLY, M.M. Rapid enzymatic determination of urinary oxalate. Clin Chem, v. 35, n. 12, p. 2330-2333, 1989.
16. LOTAN, Y. et al. Cost effectiveness of medical management strategies for nephrolithiasis. J Urol, v. 172, n. 6, p. 2275-2281, 2004. (Pubitemid 39507508)
17. MOE, O.W. Kidney stones: Pathophysiology and medical management. Lancet, v. 367, n. 9507, p. 333-344, 2006.
18. NG, R.H.; MENON, M.; LADENSON, J.H. Collection and handling of 24-hour urine specimens for measurement of analytes related to renal calculi. Clin Chem, v. 30, n. 3, p. 467-471, 1984.
19. NICAR, M.J. et al. The preservation of urine samples for determination of renal stone risk factors. Lab Med, v. 18, n. 6, p. 382-384, 1987.
20. PAK, C.Y. Medical stone management: 35 years of advances. J Urol, v. 180, n. 3, p. 813-819, 2008.
21. PAK, C.Y.; PETERSON, R.; POINDEXTER, J.R. Adequacy of a single stone risk analysis In the medical evaluation of urolithiasis. J Urol, v.165, n. 2, p. 378-381, 2001. (Pubitemid 32060417)
22. PARKS, J.H. et al. A single 24-hour urine collection is -inadequate for the medical evaluation of nephrolithiasis. J Urol, v. 167, n. 4, p. 1607-1612, 2002.
23. ROBERTSON, W.G. Mild Hyperoxaluria: a critical review and future outlook. In: Kidney Stones: Proceedings of the 8th European Symposium on Urolithiasis. Parma. Editoriale Bios, Cosenza, Italy, p. 933, 1999.
24. SHEPARD, M.D.S.; MAZZACHI, R.D. The collection, preservation, storage and stability of urine specimens for routine clinical biochemical analysis. Clin Biochem Rev, v. 4, n. 1, p. 61, 1983.
25. SIMPSON, D.P. Citrate excretion: a window on renal metabolism. Am J Physiol, v. 244, p.223-234, 1983.
26. WANDZILAK, T.R. et al. Effect of high dose vitamin C on urinary oxalate levels. J Urol, v. 151, n. 4, p. 834-837, 1994.
27. YAGISAWA, T.; CHANDHOKE, P.S.; FAN, J. Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol, v. 161, n. 5, p. 1449-1452, 1999.
28. ZERWEKH, J.E. et al. Assay of urinary oxalate: six methodologies compared. Clin Chem, v. 29, n. 11, p. 1977-1980, 1983.